397 related articles for article (PubMed ID: 38543922)
1. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030.
Al-Busafi SA; Alwassief A
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543922
[TBL] [Abstract][Full Text] [Related]
2. The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma.
Flores JE; Thompson AJ; Ryan M; Howell J
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632549
[TBL] [Abstract][Full Text] [Related]
3. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
4. Towards the elimination of hepatitis B and hepatocellular carcinoma.
Spearman CW
S Afr Med J; 2018 Aug; 108(8b):13-16. PubMed ID: 30182907
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
6. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Hepatitis B Collaborators
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):796-829. PubMed ID: 35738290
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of hepatitis B elimination in high-income countries with ongoing immigration.
Tian F; Feld JJ; Feng Z; Sander B; Wong WWL
J Hepatol; 2022 Oct; 77(4):947-956. PubMed ID: 35483535
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
9. Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021.
Khetsuriani N; Lesi O; Desai S; Armstrong PA; Tohme RA
MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(30):958-963. PubMed ID: 35900928
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
Amponsah-Dacosta E
World J Gastroenterol; 2021 Sep; 27(36):6025-6038. PubMed ID: 34629817
[TBL] [Abstract][Full Text] [Related]
11. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
12. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
[TBL] [Abstract][Full Text] [Related]
13. The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology.
Goyal A; Murray JM
PLoS One; 2014; 9(10):e110143. PubMed ID: 25313681
[TBL] [Abstract][Full Text] [Related]
14. China's efforts to shed its title of "Leader in liver disease".
Li X; Xu WF
Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
[TBL] [Abstract][Full Text] [Related]
15. Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies.
Li R; Shen M; Ong JJ; Cui F; Hu W; Chan P; Zou Z; Su S; Liu H; Zhang L; Seto WK; Wong WCW
JHEP Rep; 2023 Oct; 5(10):100833. PubMed ID: 37675271
[TBL] [Abstract][Full Text] [Related]
16. Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.
Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ
JHEP Rep; 2022 Oct; 4(10):100552. PubMed ID: 36119722
[TBL] [Abstract][Full Text] [Related]
17. Global burden of hepatitis B virus: current status, missed opportunities and a call for action.
Hsu YC; Huang DQ; Nguyen MH
Nat Rev Gastroenterol Hepatol; 2023 Aug; 20(8):524-537. PubMed ID: 37024566
[TBL] [Abstract][Full Text] [Related]
18. The current and future burden of hepatitis B in Switzerland: a modelling study.
Negro F; Müllhaupt B; Semela D; Blach S; Bruggmann P; De Gottardi A; Dufour JF; Fraga M; Galante A; Razavi H; Vieira Barbosa J; Razavi-Shearer D
Swiss Med Wkly; 2023 Jun; 153():40086. PubMed ID: 37410921
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus elimination status and strategies in circumpolar countries, 2020.
Haering C; McMahon B; Harris A; Weis N; Lundberg Ederth J; Axelsson M; Olafsson S; Osiowy C; Tomas K; Bollerup S; Liitsola K; Archibald C; Blystad H; Bruce M; Nolen L
Int J Circumpolar Health; 2021 Dec; 80(1):1986975. PubMed ID: 34668463
[TBL] [Abstract][Full Text] [Related]
20. A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia.
Sanai FM; Alghamdi M; Dugan E; Alalwan A; Al-Hamoudi W; Abaalkhail F; AlMasri N; Razavi-Shearer D; Razavi H; Schmelzer J; Alfaleh FZ
J Infect Public Health; 2020 Nov; 13(11):1715-1723. PubMed ID: 32988769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
